Literature DB >> 26847184

Clinical features and prognosis of elderly patients with hepatocellular carcinoma not indicated for surgical resection.

Akiyoshi Kinoshita1, Kazuhiko Koike1, Hirokazu Nishino1.   

Abstract

Hepatocellular carcinoma (HCC) is a major health problem worldwide. The average life expectancy during the 20th century has increased in many parts of the world, and therefore the opportunities to examine elderly HCC patients have significantly increased worldwide. Many elderly patients develop HCC with intermediate to advanced stages of disease at the initial diagnosis, and have more comorbidities and compromised liver regeneration compared with younger patients. These circumstances show that elderly patients with HCC are poorer candidates for surgical resection or transplantation. The aim of the present review was to focus on the clinical features and prognosis of elderly HCC patients not indicated for surgical resection including multimodal treatment. Although the chronological age of 60 or 65 years as the definition of an elderly person is accepted in most countries, many studies in our review article define elderly as those aged 75 years or older. Geriatr Gerontol Int 2017; 17: 189-201.
© 2016 Japan Geriatrics Society.

Entities:  

Keywords:  clinical features; elderly patients; hepatocellular carcinoma; non-surgical treatment; prognosis

Mesh:

Year:  2016        PMID: 26847184     DOI: 10.1111/ggi.12747

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  13 in total

1.  Effect of Age (over 75 Years) on Postoperative Complications and Survival in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma.

Authors:  Roberto Santambrogio; Matteo Barabino; Giovanna Scifo; Mara Costa; Marco Giovenzana; Enrico Opocher
Journal:  J Gastrointest Surg       Date:  2017-01-12       Impact factor: 3.452

Review 2.  A Review of Hepatocellular Carcinoma in Elderly Patients Focused on Management and Outcomes.

Authors:  Eunae Cho; Hyun A Cho; Chung Hwan Jun; Hee Joon Kim; Sung Bum Cho; Sung Kyu Choi
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

3.  CD90 promotes cell migration, viability and sphere‑forming ability of hepatocellular carcinoma cells.

Authors:  Ketao Zhang; Siyao Che; Zheng Su; Shangyou Zheng; Huayao Zhang; Shanglin Yang; Wenda Li; Jianping Liu
Journal:  Int J Mol Med       Date:  2017-12-08       Impact factor: 4.101

4.  Prognoses, outcomes, and clinicopathological characteristics of very elderly patients with hepatocellular carcinoma who underwent hepatectomy.

Authors:  Shingo Shimada; Toshiya Kamiyama; Tatsuya Orimo; Akihisa Nagatsu; Yoh Asahi; Yuzuru Sakamoto; Hirofumi Kamachi; Akinobu Taketomi
Journal:  World J Surg Oncol       Date:  2020-06-10       Impact factor: 2.754

5.  Therapeutic Decision Making in Hepatocellular Carcinoma According to Age and Child-Pugh Class: A Nationwide Cohort Analysis in South Korea.

Authors:  Sunmin Park; Chai Hong Rim; Young Kul Jung; Won Sup Yoon
Journal:  Can J Gastroenterol Hepatol       Date:  2021-01-04

6.  Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma.

Authors:  Guilherme Nader Marta; Leonardo G da Fonseca; Maria Ignez Braghiroli; Fernando Moura; Paulo M Hoff; Jorge Sabbaga
Journal:  Clinics (Sao Paulo)       Date:  2021-01-22       Impact factor: 2.365

7.  Comprehensive Circular RNA Profiling Reveals That hsa_circ_0005075, a New Circular RNA Biomarker, Is Involved in Hepatocellular Crcinoma Development.

Authors:  Xingchen Shang; Guanzhen Li; Hui Liu; Tao Li; Juan Liu; Qi Zhao; Chuanxi Wang
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

8.  Nrf2-mediated anti-oxidant effects contribute to suppression of non-alcoholic steatohepatitis-associated hepatocellular carcinoma in murine model.

Authors:  Shoji Yamada; Masaki Kimura; Yoshimasa Saito; Hidetsugu Saito
Journal:  J Clin Biochem Nutr       Date:  2018-04-03       Impact factor: 3.114

9.  MicroRNA-28-5p Regulates Liver Cancer Stem Cell Expansion via IGF-1 Pathway.

Authors:  Qing Xia; Tao Han; Pinghua Yang; Ruoyu Wang; Hengyu Li; Jin Zhang; Xinfeng Zhou
Journal:  Stem Cells Int       Date:  2019-12-01       Impact factor: 5.443

10.  External beam radiation therapy in a centenarian with primary liver cancer: A case report.

Authors:  Zhen Meng; Feifei Gao; Chang Liu; Shengcai Huang; Kai Hu; Rensheng Wang
Journal:  Medicine (Baltimore)       Date:  2020-11-20       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.